Celcuity Inc. (CELC) stock
CELCNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$64.17−0.15 (-0.23%)
Close on Nov 12, 2026Market cap $3.14BP/E –Yield –
Celcuity total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Celcuity's total debt was $127.86M at Mar 31, 2026. For fiscal 2025 it was $126.53M, up 29.5% from the year before. The highest annual figure on record is $126.53M in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $126.53M | +29.5% |
| FY2024 | Dec 31, 2024 | $97.73M | +163.9% |
| FY2023 | Dec 31, 2023 | $37.04M | +5.9% |
| FY2022 | Dec 31, 2022 | $34.98M | +139.2% |
| FY2021 | Dec 31, 2021 | $14.63M | – |
| FY2020 | Dec 31, 2020 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | $127.86M | +29.8% |
| Q4 FY2025 | Dec 31, 2025 | $126.53M | +29.5% |
| Q3 FY2025 | Sep 30, 2025 | $125.17M | +29.1% |
| Q2 FY2025 | Jun 30, 2025 | $99.28M | +3.2% |
| Q1 FY2025 | Mar 31, 2025 | $98.53M | +162.3% |
| Q4 FY2024 | Dec 31, 2024 | $97.73M | +163.9% |
| Q3 FY2024 | Sep 30, 2024 | $96.92M | +165.5% |
| Q2 FY2024 | Jun 30, 2024 | $96.19M | +167.3% |
| Q1 FY2024 | Mar 31, 2024 | $37.57M | +5.9% |
| Q4 FY2023 | Dec 31, 2023 | $37.04M | +5.9% |
| Q3 FY2023 | Sep 30, 2023 | $36.51M | +143.2% |
| Q2 FY2023 | Jun 30, 2023 | $35.99M | +139.7% |
| Q1 FY2023 | Mar 31, 2023 | $35.48M | +139.3% |
| Q4 FY2022 | Dec 31, 2022 | $34.98M | +139.2% |
| Q3 FY2022 | Sep 30, 2022 | $15.01M | +4.1% |
| Q2 FY2022 | Jun 30, 2022 | $15.01M | +5.4% |
| Q1 FY2022 | Mar 31, 2022 | $14.82M | – |
| Q4 FY2021 | Dec 31, 2021 | $14.63M | – |
| Q3 FY2021 | Sep 30, 2021 | $14.43M | – |
| Q2 FY2021 | Jun 30, 2021 | $14.24M | – |
| Q4 FY2020 | Dec 31, 2020 | $0 | – |
See a number that looks wrong?